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Abstract 
 
Background:  
Corneal pathology is one of the leading causes of preventible blindness in South 
Africa. A corneal transplant procedure can restore, or significantly improve vision in 
most of these patients. In current South African clinical practice however, there is a 
gross shortage of corneal tissue available to ophthalmologists to perform these 
procedures. There is little published data on corneal donations in South Africa 
describing the magnitude of the current problem.  
 
Objectives:  
To describe trends in the number of corneal donors per year, the number of corneal 
transplants performed each year, the origin of corneal donors, the allocation of 
corneas to the public or private sector and the demographics of corneal donors in 
South Africa. 
 
Methods:  
A retrospective review of all corneal donations made to South African eye banks 
during a 15-year study period from 1 January 2002 to 31 December 2016.  
 
 
Results:  
A progressive decline in corneal donors was found over the study period, from 565 
donors per year in 2002 to 89 donors in 2016. As a direct result, there has been an 
85.5% decrease in the number of corneal transplants performed per year using 
locally donated corneas, from 1049 in 2002 to 152 in 2016. 48.8% of donors 
originated from mortuaries, 39% from private hospitals and 12.2% from government 
hospitals. Donors originating from mortuaries showed the most significant declines 
over the 15 year period, decreasing by 94.8%. 79.3% of donated corneas were 
allocated to the private sector while 21.7% were allocated to the public sector. 
Demographic data showed that 69.1% of donors were male, while 30.9% were 
female. 77.2% were white, 14.0% coloured, 6.3% black and 2.5% Indian/Asian. Age 
of donors demonstrated a bimodal peak, at 25 and 55 years. 
 
Conclusion:  
The number of corneal donations in South Africa has markedly declined, causing the 
burden of corneal disease requiring corneal transplantation to continually rise. This 
study describes the magnitude and trends of the current problem in South Africa. The 
demographic data has identified certain low donor rate groups within the South 
African population, where there are possible cultural and other objections to corneal 
donation. These should serve as a major focus of future research and initiatives 
aimed at reversing the current trends. 
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CHAPTER 1: INTRODUCTION & 
LITERATURE REVIEW 
 
1.1 INTRODUCTION 
 
Corneal pathology is one of the leading causes of preventable blindness in both adult 
and paediatric populations in South Africa (SA) and around the globe.[1] A corneal 
transplant procedure (penetrating or lamellar keratoplasty) can restore, or 
significantly improve the vision in the majority of affected patients. Keratoplasty is a 
surgical technique whereby diseased cornea is removed and replaced with donor 
corneal graft tissue.  
 
In current South African clinical practice, there is a major shortage of corneal graft 
tissue available to both the private and public sector.[2] Private ophthalmologists have 
to a large extent compensated for this demand-supply inequity by importing donor 
corneas from countries such as the United States of America (USA) for example, 
where local supply of corneal tissue far exceeds their national demands. For the vast 
majority of South Africans however, the cost of these imported corneas (R20 000 – 
R25 000 per graft) makes them unaffordable. As a result, patients requiring corneal 
transplant procedures are placed on long waiting lists, for months to years before a 
cornea becomes available.[2] This prolongs visual disability in patients with a 
potentially treatable cause. In some, the delays result in sight becoming permanently 
and irrevocably lost.  
 
There is little data published on the numbers of locally harvested corneal graft 
donations being made available to private and public sector ophthalmologists in 
South Africa. A scientific letter on corneal donations at the Gauteng Cornea and Eye 
Bank reported that the numbers of corneal graft donations in Gauteng had steadily 
declined between 1998 and 2008.[3] An editorial by Meyer, without expanding on the 
exact year-to-year figures, described a 41% decline in national corneal donations in 
South Africa over a four-year period from 2003 to 2006.[2] The reasons given for the 
progressive decline in South African corneal donations were threefold: legislative 
changes in South African mortuaries, rising levels of infectious diseases in donors 
and lack of public awareness.  
 
In early 2007, the South African national waiting list for corneal transplants totaled 
1738 adults and 146 children.[2] This figure, albeit a large one, is outdated and does 
not take into account the fact that many eye clinics around South Africa have stopped 
keeping waiting lists altogether, due to the extreme scarcity of corneal tissue 
available to them.[2] This is especially the case in remote areas, far from the larger 
South African metropoles.  
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1.2 LITERATURE REVIEW 
 
BURDEN OF CORNEAL BLINDNESS GLOBALLY AND IN SOUTH 
AFRICA 
 
Global estimates of visual impairment published by the World Health Organization 
in 2010 indicate that there are 285 million visually impaired people around the globe, 
and roughly 39 million who are blind.[1,4]  Corneal pathology accounts for 
approximately 12% of blindness globally, with an estimated 4.9 million corneal blind 
persons worldwide.[5] In most developing countries, where poor socioeconomic 
circumstances play an important role in corneal diseases such as trachoma, 
xerophthalmia, onchocerchiasis (river blindness), and infective keratitis, corneal 
blindness is proportionately higher.[6,7] A study of African countries estimated 
corneal causation of blindness of up to 30% in certain regions.[8] In South Africa, the 
impact of these developing country illnesses is much less, and a population-based 
study by Cockburn from Cape Town, estimated corneal causation of blindness to be 
more closely aligned with developed country estimates at 3-4%.[9]  
 
Corneal pathology plays a more significant role in the paediatric population, with 
global estimates of corneal causation of blindness reaching 20%.[4] O’ Sullivan 
studied the aetiology of blindness in children at South African blind schools and 
found that 11% was corneal in origin.[10]Corneal blindness tends to occur at a much 
younger age than other major causes of preventable blindness such as cataracts and 
glaucoma.[11] The Disability Adjusted Life Years (DALY’s) of corneal blindness are 
thus significantly higher.[4,12] Dandona et al argue that because of the higher DALY’s 
with corneal disease, ophthalmic public health initiatives should place more 
emphasis on treating or preventing these disorders, rather than the current systems 
approach of placing highest emphasis on cataracts, which is typically a disease of the 
elderly.[9] 
 
CORNEAL TRANSPLANTATION 
 
The first successful corneal transplant procedure was a full thickness, or penetrating 
keratoplasty, performed in 1905 by Dr Edward Zirm on a farm laborer in 
Czechoslovakia who had opaque corneas following a previous chemical injury.[13] 
Over the next hundred years, penetrating keratoplasty (PKP) was established as the 
gold standard for corneal transplant procedures.[14] The cornea is an immunologically 
privileged and avascular tissue, and corneal transplantation has thus proven to be 
much more successful than other solid organ transplants. PKP has an overall graft 
survival of 90% reported at 5 years for first time grafts and 53% for re-grafts.[15] A 
study published by Wagoner on visual outcomes following full thickness corneal 
transplantation, demonstrated that PKP resulted in improvement in vision in 82.4% 
of eyes.[16]  
 
The benefit of PKP is that it is a ‘one-size-fits-all’ procedure, which can theoretically 
be performed on any eye with impaired vision due to corneal pathology.[14] Whether 
the pathology arises from the endothelium, the stroma, or involves all the layers of 
the cornea, a penetrating keratoplasty remains a suitable procedure. Penetrating 
keratoplasty is however not without its shortfalls. Major post-operative 
complications include post-PKP astigmatism, wound dehiscence, allograft rejection, 
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glaucoma and infection.[14,16,17,18] 
 
Over the last decade there has been a major shift from PKP towards partial thickness, 
or lamellar corneal transplant procedures.[13,14,18,19] Lamellar keratoplasty procedures 
such as Deep Anterior Lamellar Keratoplasty (DALK), Descemets Stripping 
Automated Endothelial Keratoplasty (DSAEK) and Descemets Membrane 
Endothelial Keratoplasty (DMEK) are targeted at specifically replacing only the 
diseased layers of the cornea, rather than the entire full thickness cornea.  
 
DALK is beginning to replace penetrating keratoplasty in diseases of the anterior 
cornea (epithelium, Bowman’s layer and stroma), where the endothelium is 
uninvolved.[16] The benefits of performing DALK rather than PKP include lower risk 
of graft rejection, less endothelial cell loss and greater long term predicted graft 
survival (49 years with DALK versus 17.3 years with PKP).[20,21,22] 
 
DSAEK has become the procedure of choice for disorders causing corneal 
endothelial dysfunction. The advantages of DSAEK over PKP include reduced post-
operative astigmatism, lower rates of wound dehiscence, avoidance of suture related 
complications and faster visual rehabilitation.[18]  
 
DMEK is a newer surgical technique, whereby only the Descemets membrane and 
endothelium are transplanted. The advantages of DMEK include improved visual 
outcomes, faster visual rehabilitation and a reduced rate of graft rejection.[18,23] 
Because there is no stromal tissue being transplanted in this procedure the antigenic 
stimulus in the graft is greatly reduced and thus the rate of allograft rejection in 
DMEK is 20 times lower than that in PKP. [24] 
 
INDICATIONS FOR CORNEAL TRANSPLANTATION 
 
General indications for corneal transplantation can be divided into four broad groups: 
1. Optical keratoplasty is aimed at improving or restoring vision in a patient with a 
variety of corneal diseases such as keratoconus, corneal dystrophies, corneal scarring 
and pseudophakic bullous keratopathy.  
2. Tectonic keratoplasty is aimed at restoring or maintaining the structural integrity 
of the cornea, for example in an eye with an infectious or inflammatory corneal melt. 
3. Therapeutic keratoplasty is aimed at removing the entire infectious focus in eyes 
with a recalcitrant infective keratitis.  
4. Cosmetic keratoplasty is aimed at improving cosmesis in a blind eye with an 
unsightly scarred or opaque cornea, but is seldom performed.[25] 
 
In 2016, a survey of Corneal Transplantation in 148 countries, described the most 
common indications for corneal transplantation as being Fuchs endothelial dystrophy 
(39%), Keratoconus (27%) and sequelae of infectious keratitis (20%).[26] In South 
Africa the most common indications for keratoplasty include keratoconus (47%), 
corneal scarring (28%) and pseudophakic bullous keratopathy (10%).[3] 
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CORNEAL DONATIONS IN SOUTH AFRICA: THE SHORTAGE OF 
CORNEAL TISSUE AND THE PAUCITY OF AVAILABLE PUBLISHED 
DATA  
 
There have been only two published reports on corneal donations in South Africa in 
the last 20 years. In 2007, an editorial by Meyer described a 41% decline in the 
number of locally harvested corneas in South Africa over a four-year period, from 
2003 to 2006.[2] This was attributed to numerous factors including legislative 
changes in forensic mortuaries in 2006, rising levels of HIV and other infections 
excluding potential donors, and a lack of public awareness around organ donation. It 
also reported that the South African national corneal transplant waiting list in 2007 
consisted of 1738 adults and 146 children.   
 
A scientific letter published in 2009 by Makgotloe on corneal donations in Gauteng 
province, described that the number of corneal donations in Gauteng had steadily 
increased from 137 in 1998 to 176 in 2005. However, in a similar trend to that 
described by Meyer, corneal donations in Gauteng then followed a state of steady 
and significant decline of more than 65% over the following three years. The number 
of donations per year dropped to 114 in 2006, 93 in 2007 and by 2008 only 57 
corneas were donated.[3] Makgotloe also described the demographic data of corneal 
donors at Gauteng eye bank. White donors accounted for 96.8%, while black, Asian 
and mixed race donors accounted for 1.6%, 1.2% ands 0.4% respectively. The 
majority of donors came from mortuaries (51.8%) and private hospitals (35%). 10% 
originated from public sector hospitals. 
 
To the best of my knowledge, there is no other published data on corneal donations 
in South Africa. 
 
PUBLIC ATTITUDES OF SOUTH AFRICANS TOWARDS ORGAN 
DONATION 
 
In 1993, Pike published an article investigating the attitudes of South Africans from 
different ethnic groups towards organ donation.[27] There was a general perception 
among healthcare workers that black South Africans were less likely to consent to 
donation of their own, or their relative’s organs, due to various cultural beliefs and 
superstitions. Pike interviewed 825 urban black, 625 rural black and 1299 urban 
white South Africans. 76% of the urban black, 84% of rural black and 89% of the 
urban white respondents indicated that they would be willing to donate their organs. 
This to some extent dispels common misconceptions about the attitudes of black 
South Africans towards organ donation in general. 
 
This was not the case however with regards to the prospect of corneal donations. 
Only 23% of black respondents said that they would be willing to donate their 
corneas, compared to a significantly higher 69% and 70%, who would be willing to 
donate their kidneys and hearts respectively. This highlights the fact that cultural 
beliefs and superstitions may play a more significant role in the donation of corneas, 
as opposed to donation of solid organs. These potential barriers would need to more 
adequately defined and specifically addressed in any programs aimed at improving 
uptake of corneal donation in South Africa. 
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All race groups were less comfortable with the idea of consenting to the donation of 
the organs of one of their close relatives. Most respondents felt that the principal 
donor, prior to their demise, should preferably be the one responsible for making this 
decision, and not the family member after death. Most respondents across all race 
groups felt that the race of both the donor and the recipient was irrelevant in organ 
donation.  
 
EYE BANKING 
 
A) HISTORY OF EYE BANKING GLOBALLY 
 
An eye bank is an organization that acquires, prepares, evaluates, stores and 
distributes donated corneas for use in corneal transplantation.  
 
From the time of the first corneal transplant by Edward Zirm in 1905, until the mid-
1930’s, the only source of corneal tissue was from living donors who had undergone 
an enucleation for pathology involving only the posterior segment of the eye.[28] 
There were no means available for storage of these corneas and prevention of cell 
death and thus transplantation had to be performed immediately after enucleation. In 
1937, a Russian ophthalmologist, Vladimir Filatov, discovered that cadaver corneal 
tissue could be stored in a moisture chamber at 40 C for 24-36 hours post mortem.[29] 
This means of storing corneal tissue, albeit for a short time period was the initiating 
event, that would later develop into eye banking.  
 
A scientific breakthrough in the 1970’s saw the development of the McKarey-
Kaufman tissue medium, which allowed corneas to be stored at 40C for up to 4 days. 
[30] Further advancements in tissue preservation saw the development of Organ 
Culture Medium, which could safely store corneas at 340C for up to 35 days. Later 
refinements led to the production of commercially available storage media such as 
Optisol, which allow a simple and safe storage solution at 40C for 14-21 days.[31] 
This meant that corneal transplantation no longer needed to be performed as an 
emergency procedure, but could now be scheduled on a semi-elective basis, with 
better preparation of the recipient, analysis of the donor cornea and availability of 
appropriate expertise during working hours. 
 
The worlds first Eye Bank was founded in 1944 in New York by Richard Townley 
Paton. The aim of the eye bank was to collect, store and then distribute corneal tissue 
to qualified ophthalmic surgeons.[32] Over the next 15 years, there was an ever-
increasing number of eye banks being established across the United States of 
America (USA). In 1961, the Eye Bank Association of America (EBAA) was 
established in order to better co-ordinate and administer the efforts of all of the 
American Eye Banks. The EBAA now consists of 71 USA-based and 10 
international-affiliated eye banks. The most recent EBAA statistical report shows 
that 79 304 corneas were supplied for keratoplasty in 2015 alone.[33] 65% of these 
were distributed to corneal surgeons within the USA, while 35% were exported 
internationally to countries including South Africa.[34] Numerous other similar eye 
bank Associations have subsequently been established around the globe. 
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B) HISTORY OF EYE BANKING IN SOUTH AFRICA 
 
The first South African eye bank, the Eye Bank Foundation of South Africa was 
established in Cape Town in 1975.[35] Over the following 30 years, additional eye 
banks were opened in Gauteng, Pretoria, Port Elizabeth and KwaZulu Natal, so that 
by 2003, there were five operational eye banks in South Africa. Unfortunately as a 
result of increasingly strict legislature and financial difficulties, both the Port 
Elizabeth eye bank and the Pretoria eye bank closed operations at the end of 2010, 
leaving only three remaining banks. In 2011 however, the Centre for Tissue 
Engineering in Pretoria, an organization already functioning as a tissue bank for skin, 
bone, tendons and heart valves, started harvesting and distributing corneas as well. 
Thus in 2017, there are essentially four eye banks still operating in South Africa. 
 
MECHANISMS TO INCREASE ORGAN DONATIONS RATES 
 
A) LEGISLATIVE CHANGES 
 
Legislature and national policies regarding organ and tissue donation vary widely 
around the globe. In broad terms however, two main systems have been adopted, 
namely an ‘opt-in’ system and an ‘opt-out’ system. An ‘opt-in’ system means that 
citizens have to make an active decision prior to death that they would like to be an 
organ donor upon their demise. This decision can be made in various forms, such as 
signing up to an organ donor registry, informing family members, or in the form of a 
living will. An ‘opt-out’ system however, means that consent to organ donation is 
presumed, unless a specific request has been made known prior to death, that the 
person does not wish to become on organ donor on their demise. This decision can 
be made known by various similar means to those described above.  
 
A large-scale review published by a group from Nottingham University in 2014 
compared organ donation rates in 48 countries over a 13-year period, from 2000 to 
2012. They noted that organ donation rates were significantly higher in countries that 
adopted an ‘opt-out’ organ donation system.[36] After legislative changes 
implemented in 2015, Wales was the first country in the United Kingdom (UK) to 
adopt a variation of the ‘opt-out’ system, termed a ‘soft opt-out’ system. The main 
difference is that the family is still consulted in the final decision-making after death, 
and if the deceased had expressed that he or she did not wish to be an organ donor, 
then the family can opt-out on their behalf. Early reports suggest a 24% increase in 
transplants since the introduction of this system.[37] In June 2016, the British Medical 
Association, representing 150 000 doctors in the UK, voted in favour of a 
referendum to lobby the British government to change the legislature to an opt-out 
organ donation system for the entire UK.  
 
B) ORGANIZATION AND PROFESSIONALIZATION OF ORGAN 
DONATION 
 
Organ donation rates are expressed as donors per million population (pmp). World 
leaders in organ donation such as Spain, have organ donation rates of >30 pmp, 
while other developed countries such as the USA, France and Italy have rates 
between 20 and 30. The UK and Germany have lower rates in the mid teens. [38] 
South Africa by stark contrast has one of the lowest organ donation rates in the 
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world, at just 2-3 pmp.[39] Legislative change to an opt-out system alone however, 
does not necessarily guarantee an increase in organ donations. Singapore for 
example, is the only country with an enforced ‘opt-out’ system. In this system if a 
person has not explicitly opted out of organ donation prior to being declared brain 
dead, they are presumed to consent to organ donation, and their family cannot 
override this consent after their demise. Although this legislative change resulted in a 
50-fold increase in the number potential donors, the actual donor rate has remained 
relatively low at 7-9 pmp.[40] This is because of lack of an organized transplant 
program in hospitals to convert potential donors into actual donors. 
 
Thus, while legislative changes do increase the numbers of potential donors, the 
conversion rate to increasing the number of actual donors relies on various other 
factors, which have been the major focus of the highly effective ‘Spanish Model’ of 
organ donation described below. Spain, in addition to utilizing a soft opt-out system, 
established a highly efficient National Transplant Organization (ONT) in 1989. This 
organization, which is run by the Spanish health department, ensures a high 
conversion rate of potential donors into actual donors. The ONT has achieved this by 
introducing the role of Transplant Donor Coordinators (TDC’s) into every hospital in 
Spain. The TDC’s are mostly ICU physicians, and more recently nursing sisters. 
They undergo special training and play a vital role in promoting organ donation 
within their hospital by identifying potential donors, discussing organ donation with 
family members, and referring the organ donor to a transplant team after brain death. 
The Spanish Model also relies on a stringent Quality Assurance Program, which 
regularly audits organ donation practices, in order to identify possible areas for 
improvement. [38] These strategies have proven highly effective in pivoting Spain to 
the position of world leader in organ donation. 
 
 
1.3 OBJECTIVES 
 
The main objectives of this study are to obtain and analyze South African corneal 
donor data over a 15-year period from 1 January 2002 to 31 December 2016, 
describing: 
i. The trends in numbers of corneal donors per year 
ii. The trends in corneal transplants performed per year using locally donated 
corneas 
iii. The origin of corneal donors, whether from public hospitals, private hospitals 
or mortuaries  
iv. The allocations of corneal graft tissue, whether to the public or private health 
care sectors 
v. The demographics of corneal donors in South Africa  
 
 
1.4 JUSTIFICATION FOR THE STUDY 
 
The first step in the process of reversing the current situation of declining corneal 
donations in South Africa, is to publish current data and highlight trends in corneal 
donations, both nationally and at the level of the individual eye banks. Once this 
information is obtained, it can be presented to government and eye bank policy-
makers and used to motivate for new strategies and legislative changes to increase 
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corneal donations in South Africa. The data on the demographics of corneal donors 
will identify low donor rate groups, which should be the focus of future research and 
initiatives to increase donations and relieve the current shortage of corneal tissue 
experienced in South African clinical practice.  
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Abstract  
 
Background:  
Corneal pathology is one of the leading causes of preventible blindness in South 
Africa. A corneal transplant procedure can restore, or significantly improve vision in 
most of these patients. In current South African clinical practice however, there is a 
gross shortage of corneal tissue available to ophthalmologists to perform these 
procedures. There is little published data on corneal donations in South Africa 
describing the magnitude of the current problem.  
 
Objectives:  
To describe trends in the number of corneal donors per year, the number of corneal 
transplants performed each year, the origin of corneal donors, the allocation of 
corneas to the public or private sector and the demographics of corneal donors in 
South Africa. 
 
Methods:  
A retrospective review of all corneal donations made to South African eye banks 
during a 15-year study period from 1 January 2002 to 31 December 2016.  
 
 
Results:  
A progressive year-on-year decline in corneal donors was found over the study 
period, from 565 donors per year in 2002 to 89 donors in 2016. As a direct result, 
there has been an 85.5% decrease in the number of corneal transplants performed per 
year using locally donated corneas, from 1049 in 2002 to 152 in 2016. 48.8% of 
donors originated from mortuaries, 39% from private hospitals and 12.2% from 
government hospitals. Donors originating from mortuaries showed the most 
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significant declines over the 15 year period, decreasing by 94.8%. 79.3% of donated 
corneas were allocated to the private sector while 21.7% were allocated to the public 
sector. Demographic data showed that 69.1% of donors were male, while 30.9% 
were female. 77.2% were white, 14.0% coloured, 6.3% black and 2.5% Indian/Asian. 
Age of donors demonstrated a bimodal peak, at 25 and 55 years. 
 
Conclusion:  
The number of corneal donations in South Africa has markedly declined, causing the 
burden of corneal disease requiring corneal transplantation to continually rise. This 
study describes the magnitude and trends of the current problem in South Africa. The 
demographic data has identified certain low donor rate groups within the South 
African population, where there are possible cultural and other objections to corneal 
donation. These should serve as a major focus of future research and initiatives 
aimed at reversing the current trends. 
 
Keywords:  
Corneal donations, South Africa 
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Background 
Corneal pathology is one of the leading causes of preventable blindness around the 
globe, accounting for approximately 4% of preventable blindness worldwide.[1,2] 
Corneal disease is the cause of visual loss in 11% of blind or severely visually-
impaired children and 4% of blind adults in South Africa (SA).[3,4] A corneal 
transplant procedure (penetrating or lamellar keratoplasty) can restore or 
significantly improve vision in the majority of affected patients. Keratoplasty is a 
surgical procedure whereby diseased cornea is removed and replaced with donor 
corneal graft tissue. Modern advances in surgical techniques and surgeon expertise 
have resulted in continual improvements in visual outcomes with these 
procedures.[5,6,7] 
 
In South African clinical practice, there is a major shortage of corneal graft tissue 
available to both the private and public sector. Private sector ophthalmologists have, 
to a large extent, compensated for this demand-supply inequity by importing donor 
corneas from countries such as the United States of America for example, where 
local supply of corneal tissue far exceeds their national demands.[8] For the vast 
majority of South Africans however, the cost of these imported corneas (R20 000 – 
R25 000 per graft) makes them unaffordable.[9] As a result, patients requiring corneal 
transplant procedures are placed on long waiting lists, for months to years before a 
cornea becomes available.[9] This only prolongs visual disability in patients with a 
potentially treatable cause. In some, these delays result in sight becoming 
permanently and irrevocably lost.  
 
Published data on the numbers of locally harvested corneal graft donations being 
made available to private and public sector ophthalmologists in South Africa is 
scarce. A scientific letter on corneal donations at the Gauteng Cornea and Eye Bank 
reported that the numbers of corneal graft donations in Gauteng had steadily 
diminished between 1998 and 2008.[10] An editorial written by Meyer, without 
expanding on the exact year-to-year figures, described a 41% decline in national 
corneal donations in South Africa over the four-year period from 2003 to 2006.[9] 
The reasons given for the progressive decline in South African corneal donations 
were threefold: legislative changes in South African mortuaries, rising levels of 
infectious diseases in donors and lack of public awareness. The most recent 
published figure for the South African national corneal transplant waiting list was in 
2007, and totaled 1 738 adults and 146 children.[9] This figure, albeit a large one, is 
outdated and likely a gross underestimate of the current situation. The number of 
people waiting for corneal transplantation will continue to rise, unless strategies are 
implemented to reverse these trends. 
 
Objectives 
To describe trends in the number of corneal donors per year, the number of corneal 
transplants performed each year, the origin of corneal donors, the allocation of 
corneas and the demographics of corneal donors in South Africa. 
 
Methods 
A retrospective review was conducted of all corneal donations made to South 
African eye banks that were operational at any time during the 15-year study period, 
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from 2002 to 2016. Data collection templates were sent to the directors of the four 
currently operational South African eye banks, namely the Gauteng Cornea & Eye 
Bank in Johannesburg, the Eye Bank Foundation of South Africa in Cape Town, the 
KwaZulu-Natal Cornea & Eye Association in Durban and the Centre for Tissue 
Engineering (CTE) in Pretoria (which began eye banking in 2012, after the closure of 
the previously operational Pretoria eye bank in 2010). Data was extracted from the 
pre-existing databases kept by the various eye bank directors on corneal donations in 
each of their respective banks. The data collection templates were designed to 
capture information on the numbers of corneal donors per year, the numbers of 
corneal transplants performed per year using corneas donated to each of the local eye 
banks, the origin of corneal donors, the distribution of allocated corneas to the public 
and private health care sectors and the demographics of corneal donors. 
 
The Pretoria Eye Bank and the Port Elizabeth Goosen Eye Bank both closed 
operations in 2010. The closure of these two eye banks meant that data available 
from these institutions was limited only to the number of corneal transplants 
performed per year using graft donations to these banks. No other information on 
origin of donors, allocation of grafts or donor demographics was available from these 
banks.  
 
This study was approved by the Human Research Ethics Committee, Faculty of 
Health Sciences, University of Cape Town (HREC/REF:883/2014) and conformed to 
the principles of the 2013 Declaration of Helsinki.[11] 
 
Results 
 
There were a total of 3 738 corneal donors nationally in South Africa from 2002-
2016 (Table 1). Given the fact that in most cases, each corneal donor is able to 
donate two corneas, this translated into 6 588 locally-donated corneal grafts being 
supplied for corneal transplant procedures over the 15 year study period (Table 2).  
The Gauteng Cornea and Eye Bank supplied 2 530 corneas (38.4%), the Cape Town 
Eye Bank (Eye Bank Foundation of South Africa) supplied 1 805 corneas (27.4%), 
the combined efforts of the Pretoria Eyebank from 2002-2010 and the CTE from 
2012-2016 (both operating in Pretoria) supplied 1 195 corneas (18.1%), the KZN 
Cornea and Eye Association supplied 931 corneas (14.1%) and the Port Elizabeth 
Goosen Eye Bank supplied 127 corneas (2%). 10.5% of the donated corneas were 
either discarded or donated for research purposes. The main reasons for discarding 
donated corneas included positive donor virology (HIV, Hepatitis B and C), low 
endothelial cell count (<2000cells/mm2), damaged or scarred grafts and a positive 
culture on a swab taken from the graft. 
 
 
 
 
 
 
 
 
 
 
	 22	
 
Table 1. Number of corneal donors* per year at the South African eye banks  
 
Year Gauteng† Cape 
Town† 
KZN† Pretoria† Port 
Elizabeth† 
Nationally 
2002 184 164 0 207‡ 10‡ 565 
2003 166 173 42 140‡ 5‡ 526 
2004 137 176 48 58‡ 9‡ 428 
2005 162 172 46 52‡ 5‡ 437 
2006 110 85 67 38‡ 11‡ 311 
2007 88 48 38 33‡ 8‡ 215 
2008 57 46 50 22‡ 11‡ 186 
2009 86 40 32 33‡ 2‡ 193 
2010 70 37 31 2‡ 9‡ 149 
2011 58 37 26 0 0 121 
2012 68 33 27 23 0 151 
2013 56 31 29 26 0 142 
2014 63 17 26 21 0 127 
2015 51 11 18 18 0 98 
2016 45 17 19 8 0 89 
Total 1 401 1 087 499 681 70 3 738 
*Note: a corneal donor refers to one deceased individual, with the potential to donate 
two corneas in the majority of cases. 
 
† Gauteng= Gauteng Cornea and Eye Bank, Cape Town=Eye Bank Foundation of 
South Africa, KZN= KwaZulu Natal Cornea and Eye Association, Pretoria= Pretoria 
Eye Bank (2002-2010) and CTE (2012-2016), Port Elizabeth= Port Elizabeth 
Goosen Eye Bank  
 
‡ Numbers from the Pretoria and Port Elizabeth eye banks from 2002-2010 are 
estimates of corneal donor numbers per year calculated from available data on 
number of actual corneal grafts donated to these banks per year and adjusted for a 
mean of 2 corneal grafts per donor and an average discard rate for donated corneal 
grafts of 10.5%. The figure of 10.5% is the mean discard rate calculated from data 
from the Gauteng, Cape Town and KZN eye banks, where more data was available. 
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Table 2. Number of corneal transplants per year using corneas donated to the
    South African eye banks 
 
Year Gauteng Cape 
Town 
KZN Pretoria Port   
Elizabeth 
Nationally 
2002 344 315 0 372 18 1 049 
2003 296 290 72 250 9 917 
2004 259 286 77 104 17 743 
2005 289 263 88 93 9 742 
2006 199 138 129 68 20 554 
2007 168 85 77 59 14 403 
2008 103 79 93 39 19 333 
2009 149 68 56 59 4 336 
2010 118 61 58 4 17 258 
2011 106 64 46 0 0 216 
2012 125 42 53 34 0 254 
2013 101 37 58 38 0 234 
2014 104 28 50 36 0 218 
2015 95 21 36 27 0 179 
2016 74 28 38 12 0 152 
Total 2 530 1 805 931 1 195 127 6 588 
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Trends in numbers of corneal donors per year 
The trendline graph of corneal donors nationally (Figure 1) shows a progressive 
decline in corneal donors from 565 donors in 2002 to 89 donors in 2016, an 84.2% 
decline over the 15 year study period. The most significant decline occurred in the 
period from 2005 to 2007, with a 50.9% drop in donor numbers occuring during that 
2 year period alone. The trend of progressively decreasing corneal donor numbers 
was consistent across all of the South African eye banks. 
 
 
 
Figure 1. Trendline graph of number of corneal donors per year nationally 
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Trends in numbers of corneal transplants performed per year, using corneas 
donated to the South African eye banks  
The trends in the number of corneal transplants performed nationally per year, using 
locally donated corneas, mirrors that found with numbers of corneal donors. The 
number of transplants per year decreases significantly and progressively (Figure 2), 
with an 85.5% decrease over the 15 year period, from 1 049 at the start of the study 
in 2002, to just 152 at the end of the study in 2016. As with the drop in corneal 
donors, the most significant decrease in numbers occured over the period from 2005 
to 2007, with a 45.7% decrease occuring during this time. Again this trend of 
progressively decreasing numbers of corneal transplants performed per year is 
consistent across all of the eye banks. 
 
 
 
Figure 2. Trendline graph of number of corneal transplants per year nationally 
     using corneas donated to the South African eye banks 
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Origin of corneal donors  
Data on the origin of corneal donors was obtained from the three South African eye 
banks which were operational for the entire study period, namely the Gauteng, Cape 
Town and KZN eye banks. Over the 15 year study period, 1 443 donors (48.8%) 
originated from mortuaries, 1 151 (39%) from private hospitals and 361 (12.2%) 
from government hospitals. For 32 donors, the origin was unknown. The number of 
donors per year arising from private hospitals remained fairly constant over the study 
period, while the number of donors originating from government hospitals appears to 
be slowly declining (Figure 3). The number of donors originating from mortuaries 
showed the most significant reductions over the study period, decreasing by 94.8% 
from 211 donors per year in 2002 to 11 donors per year in 2016 (Figure 3). Again, 
the most significant declines occurred over the period from 2005 to 2007, with a 
69.8% decline occuring during this time. 
 
 
 
 
Figure 3. Trendline graph of origin of corneal donors  
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Allocation of donated corneas 
Of the corneas donated to the Gauteng, Cape Town and KZN eye banks, 4 041 
(79.3%) were allocated to private sector patients for corneal transplantation, while    
1 058 (20.7%) were allocated to the public sector. The distribution of corneas 
allocated to public and private sector patients at the Gauteng, Cape Town and KZN 
eye banks is demonstrated in Figure 4. 
 
Figure 4. Allocation of corneal grafts at three South African eye banks 
 
 
 
Demographics of corneal donors 
Data on donor demographics was only available from the Gauteng, Cape Town and 
KZN eyebanks. 
 
a) Gender of corneal donors 
2 064 (69.1%) of the donors were male and 923 (30.9%) were female. This 
approximately 2:1 ratio was consistent across all three eye banks. 
 
b) Race of corneal donors 
2 280 (77.2%) of the donors were white, 413 (14.0%) were coloured, 186 (6.3%) 
were black and 73 (2.5%) were Indian/Asian. White donors made up the largest 
donor racial group in all three banks, but the proportions of donor races varied 
substantially (Figure 5). The race was unknown in 35 donors. 
 
Figure 5. Race of corneal donors 
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c) Age of corneal donors 
Of the 2 987 donors at the three major eye banks, 342 (11.7%) were aged between 0-
20 years, 957 (32.8%) were aged between 21-40 years, 1 099 (37.7%) were aged 
between 41-60 years and 519 (17,8%) were aged between 61-80 years. The age was 
unknown in 70 donors. There was a bimodal peak in age of donors at 25 and 55 years 
(Figure 6).  
 
Figure 6. Age distribution of corneal donors 
 
 
 
Discussion 
This study highlights the alarming trend of progressively decreasing numbers of 
corneal donors in South Africa over the 15 year period. The rapid decline in numbers 
which occurred between 2005 and 2008 coincides with a time of legislative change 
affecting South African forensic mortuaries. Prior to 2006, the South African Police 
Services (SAPS) controlled and managed the forensic mortuaries. Eye bank directors 
had liberal access to information on deceased persons in the mortuaries and were 
thus able to easily identify potential donors and contact their next of kin. This made 
mortuaries the main source of corneal donors at the time. In 2006 however, changes 
in legislation shifted the governance of the forensic mortuaries from the SAPS to the 
Department of Health (DOH). The new legislation, with good intention, placed high 
emphasis on ethical considerations and confidentiality of deceased individuals at the 
forensic mortuaries. As a consequence of this, access to information on potential 
donors from the mortuaries was dramatically restricted. In addition, new protocols 
were instituted in mortuaries, which stipulated that telephonic consent from family 
members was no longer sufficient, and that written consent would be required from a 
family member who had identified the deceased in person. Given the fact that the 
time from death to the harvesting of corneas should ideally be within 12 hours, this 
was very seldom possible. The result was a rapid fall in donors originating from the  
forensic mortuaries from 2006 onwards. By 2007, this source of corneal donors had 
fallen to levels below that of donors originating from private hospitals, and these 
numbers continued to decline throughought the study period.  
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The corneal donors originating from private and government hospitals were 
individuals who were either registered organ donors, or whose family members had 
consented to their organ donation after brain death had been declared. Transplant co-
ordinators liase with teams to harvest solid organs and other tissues and contact the 
relevant eye bank to harvest the corneas. While the number of corneal donors 
originating from private hospitals has remained fairly constant throughout the 15-
year study period, and currently makes up the highest source of corneal donors, the 
actual numbers of donors remain low. The numbers of donors originating from 
government hospitals has always been low and has progressively decreased over the 
study period. Poor public awareness of organ donation, cultural issues regarding 
organ donation, high HIV and Hepatitis prevalence and poor education and ‘buy-in’ 
of medical personnel toward referral of potential donors to transplant co-ordinators, 
have all contributed to the low numbers of corneal donors in our government 
hospitals.[9, 10, 12] In addition, by global standards, South Africa has a very limited 
national organ transplant co-ordination program and little government support and 
funding towards organ donation.[13, 14] Therefore only a very small proportion of 
patients dying in South African government hospitals become organ donors.  
 
More than two thirds of donated corneas are allocated to the private sector at all three 
of the major eye banks, even though there is much greater demand for corneas in the 
public sector. The reasons for this are two-fold. First, there is no current national 
system for equitable distribution of corneas between public and private healthcare 
sectors. At present, most of the eye banks treat each private practice ophthalmologist 
and each public sector ophthalmology department as individual practioners and 
attempt to evenly distribute the corneas amongst all of these practitioners. Because 
there are many more private ophthalmologists than public ophthalmology 
departments, this system is heavily skewed in favour of the private sector.[15] The 
second reason is financial. Eye banks are non-profit organisations, whose sources of 
income to cover running costs and salaries arise from donations and remuneration for 
corneal tissue supplied. Thus while private sector patients are able to pay for corneal 
tissue through medical aid funds or personal finances, public health sector 
ophthalmology departments have very limited budgets available to pay for corneal 
graft tissue and a much slower turnaround time for payments.[10]  
 
There was an approximately 2:1 male preponderance in corneal donors. As 48.8% of 
donors originated from forensic mortuaries, a large proportion would have died from 
unnatural deaths, such as motor-vehicle related accidents, other accidental deaths, 
murders or suicides. Males are three times more likely than females to die of an 
unnatural death in South Africa, especially in the younger age group between 15-29 
years.[16] It is unknown whether gender itself influences attitudes towards organ 
donation in South Africa, and this may be a topic for future research. 
 
White donors made up the highest proportion in all three major eye banks, despite 
being one of the smaller race groups in South Africa. Conversely, black South 
Africans, the largest race group comprising 79.2% of our population,[17] accounted 
for a small fraction of the corneal donor pool. This is likely due to cultural beliefs 
towards organ donation amongst black South Africans. In a survey on public 
attitudes towards organ donation in South Africa, Pike found that while up to 70% of 
black respondents said that they would be willing to donate solid organs, only 23% 
would be willing to donate their corneas.[12] Cultural beliefs and superstitions may 
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therefore play an even more significant role in the donation of corneas than in the 
donation of other solid organs. The possible cultural barriers towards corneal 
donation amongst black South Africans requires further investigation and should be a 
key focus point in programs aimed at improving uptake of corneal donations in 
South Africa. The low number of Indian/Asian donors is likely due to religious 
beliefs. In the Muslim faith for example, there is divided opinion on organ donation, 
with some Islamic scholars saying that it is strictly prohibited, whilst others argue 
that the act of saving another’s life should make it permissible.[18] The higher 
proportion of Indian/Asian donors at the KZN eye bank and of coloured donors at the 
Cape Town eye bank are likely a reflection of the differences in racial demographics 
in these respective provincial population groups.[17] The bimodal peak in age of 
donors at 25 and 55 years reflects the fact that the majority of unnatural causes of 
death occur in the age group between 15-29 years, while the majority of natural 
causes of death occur in patients over the age of 45.[16]  
 
This study clearly defines the magnitude of the current corneal donor shortage and 
the alarming trend of progressively declining corneal donations in South Africa. Our 
hope is that this information can be used as a platform on which future strategies 
aimed at reversing these trends can be built. One of the main reasons for the marked 
decrease in number of corneal donors, has been the legislative changes affecting 
South African forensic mortuaries. Negotiations should be opened with the 
Department of Health (DoH) as to what measures can be taken to improve the 
numbers of corneal donors originating from forensic mortuaries, while still 
maintaining ethical principles and complying with the Protection of Public 
Information (PoPI) Act. Other legislative changes which could benefit not only 
corneal donations, but solid organ donations as well, would be a move from the 
current ‘opt-in’ organ donation system, to an ‘opt-out’ system. An ‘opt-out’ system 
means that all members of the public are presumed to consent to organ donation, 
unless they take an active step to opt-out. A large-scale review published by a group 
from Nottingham University in 2014 compared organ donation rates in 48 countries 
over a 13-year period, from 2000-2012. They noted that organ donation rates were 
significantly higher in countries adopting an ‘opt-out’ system.[19] Wales is the first 
country in the UK to shift to an ‘opt-out’ system in 2015, resulting in a 24% increase 
in transplants in the first year.[20] In June 2016, the British Medical Association, 
representing 150 000 doctors in the UK, voted in favour of a referendum to lobby the 
British government to change the legislature to an ‘opt-out’ organ donation system 
for the entire UK. Spain is the currently the world leader in organ donations, with an 
organ donation rate of more than 30 per million population (pmp),[13] compared to 
South Africa’s rate of 2-3 pmp, which is one of the lowest worldwide.[14] The reasons 
for the huge success of the ‘Spanish Model’ of organ donation lies not only in their 
‘opt-out’ legislation, but more importantly in their highly organized and professional 
National Transplant Organization (ONT). This state funded organization, which is 
run by the Spanish health department, introduced the role of Transplant Donor 
Coordinators (TDC’s) into every hospital in Spain. The TDC’s promote organ 
donation within their hospital, identify potential donors, discuss organ donation with 
family members, and refer the organ donor to a transplant team after brain death. 
Similar strategies could be considered by South African policy-makers. 
 
Already there are promising local initiatives attempting to reverse the current trends. 
The Organ Donor Foundation (ODF) was established in 1988, with their primary 
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mandate being to raise public awareness of organ donation in South Africa. Another 
important collaboration was inaugurated in September 2015, with the formation of 
the South African Tissue Bank Association (SATiBA).  Its purpose is to unite the 
previously independantly operating eye banks and the other tissue banks (harvesting 
other tissues such as bone, skin, marrow and others) together under one umbrella 
body. The objectives are to improve public awareness, standardise procedural 
protocols, improve education and training of staff and volunteers, improve electronic 
data collection and publication of donation statistics and support the individual banks 
in legal and regulatory matters. Most importantly, it aims to consolidate efforts at 
lobbying government and key policy makers to implement new strategies, changes in 
legislature and the prioritization of funding, in order to improve the numbers of 
corneal and other tissue donations in the future.[21]  
 
Conclusion  
The number of corneal donations in South Africa has markedly declined and this has 
been a major contributing factor to the continually rising burden of corneal disease 
requiring corneal transplantation. This study describes the magnitude and trends of 
the current problem in South Africa. The demographic data has identified certain low 
donor rate groups within the South African population, where there are possible 
cultural and other objections to corneal donation. These should serve as a major 
focus of future research and initiatives aimed at reversing the current trends. 
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APPENDICES 
 
1) DATA COLLECTION TEMPLATES 
 
a) Number of corneal donors per year to your eye bank  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b) Number of corneal transplants per year using corneas donated to your 
    eye bank  
 
Year Number of Corneal Transplants 
2002  
2003  
2004  
2005  
2006  
2007  
2008  
2009  
2010  
2011  
2012  
2013  
2014  
2015  
2016  
 
 
Year Number of Corneal Donors 
2002  
2003  
2004  
2005  
2006  
2007  
2008  
2009  
2010  
2011  
2012  
2013  
2014  
2015  
2016  
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c) Origin of Corneal Donors 
 
Year Private Hospitals Government Hospitals Mortuaries 
2002    
2003    
2004    
2005    
2006    
2007    
2008    
2009    
2010    
2011    
2012    
2013    
2014    
2015    
2016    
  
 
d) Allocation of Corneas 
 
Year Corneas allocated to private 
sector patients 
Corneas allocated to Public 
sector patients 
Total Number of Corneas 
allocated 
2002    
2003    
2004    
2005    
2006    
2007    
2008    
2009    
2010    
2011    
2012    
2013    
2014    
2015    
2016    
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e) Gender of Corneal Donors 
 
Year Female Male 
2002   
2003   
2004   
2005   
2006   
2007   
2008   
2009   
2010   
2011   
2012   
2013   
2014   
2015   
2016   
 
 
f) Race of Corneal Donors 
 
Year White Black Indian/Asian Coloured 
2002     
2003     
2004     
2005     
2006     
2007     
2008     
2009     
2010     
2011     
2012     
2013     
2014     
2015     
2016     
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g) Age of Corneal Donors 
 
Year 0-10 yrs 11-20 yrs 21-30yrs 31-40yrs 41-50yrs 51-60yrs 61-70yrs 71-80yrs 
2002         
2003         
2004         
2005         
2006         
2007         
2008         
2009         
2010         
2011         
2012         
2013         
2014         
2015         
2016         
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2) DEPARTMENT OF SURGERY RESEARCH COMMITTEE 
APPROVAL 
 
 
 
 
	 39	
3) ETHICS APPROVAL 
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4) ETHICS RENEWAL WITH CHANGE OF DURATION OF STUDY 
TO 15 YEARS 
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5) SOUTH AFRICAN MEDICAL JOURNAL (SAMJ) INSTRUCTIONS 
TO AUTHORS 
 
Author Guidelines 
 
General article format/layout 
Accepted manuscripts that are not in the correct format specified in these guidelines 
will be returned to the author(s) for correction, which will delay publication. 
  
General: 
• Manuscripts must be written in UK English. 
• The manuscript must be in Microsoft Word or RTF document format. Text must 
be single-spaced, in 12-point Times New Roman font, and contain no 
unnecessary formatting (such as text in boxes). 
• Please make your article concise, even if it is below the word limit. 
• Qualifications, full affiliation (department, school/faculty, institution, city, 
country) and contact details of ALL authors must be provided in the 
manuscript and in the online submission process. 
• Abbreviations should be spelt out when first used and thereafter used consistently, 
e.g. 'intravenous (IV)' or 'Department of Health (DoH)'. 
• Scientific measurements must be expressed in SI units except: blood pressure 
(mmHg) and haemoglobin (g/dL). 
• Litres is denoted with an uppercase L e.g. 'mL' for millilitres). 
• Units should be preceded by a space (except for % and ºC), e.g. '40 kg' and '20 cm' 
but '50%' and '19ºC'. 
• Please be sure to insert proper symbols e.g. µ not u for micro, a not a for alpha, b 
not B for beta, etc. 
• Numbers should be written as grouped per thousand-units, i.e. 4 000, 22 160. 
• Quotes should be placed in single quotation marks: i.e. The respondent stated: '...' 
• Round brackets (parentheses) should be used, as opposed to square brackets, 
which are reserved for denoting concentrations or insertions in direct quotes. 
• If you wish material to be in a box, simply indicate this in the text. You may use 
the table format –this is the only exception. Please DO NOT use fill, format 
lines and so on. 
  
 
Preparation notes by article type  
Research 
Guideline word limit: 4 000 words 
  
Research articles describe the background, methods, results and conclusions of an 
original research study. The article should contain the following sections: 
introduction, methods, results, discussion and conclusion, and should include a 
structured abstract (see below). The introduction should be concise – no more than 
three paragraphs – on the background to the research question, and must include 
references to other relevant published studies that clearly lay out the rationale for 
conducting the study. Some common reasons for conducting a study are: to fill a gap 
in the literature, a logical extension of previous work, or to answer an important 
clinical question. If other papers related to the same study have been published 
previously, please make sure to refer to them specifically. Describe the study 
	 42	
methods in as much detail as possible so that others would be able to replicate the 
study should they need to. Results should describe the study sample as well as the 
findings from the study itself, but all interpretation of findings must be kept in the 
discussion section, which should consider primary outcomes first before any 
secondary or tertiary findings or post-hoc analyses. The conclusion should briefly 
summarise the main message of the paper and provide recommendations for further 
study. 
  
Select figures and tables for your paper carefully and sparingly. Use only those 
figures that provided added value to the paper, over and above what is written in the 
text. 
Do not replicate data in tables and in text . 
  
Structured abstract 
• This should be 250-400 words, with the following recommended headings: 
◦ Background: why the study is being done and how it relates to other 
published work. 
◦ Objectives: what the study intends to find out 
◦ Methods: must include study design, number of participants, description of 
the intervention, primary and secondary outcomes, any specific 
analyses that were done on the data. 
◦ Results: first sentence must be brief population and sample description; 
outline the results according to the methods described. Primary 
outcomes must be described first, even if they are not the most 
significant findings of the study. 
◦ Conclusion: must be supported by the data, include recommendations for 
further study/actions. 
• Please ensure that the structured abstract is complete, accurate and clear and has 
been approved by all authors. 
• Do not include any references in the abstracts. 
   
Main article 
All articles are to include the following main sections: Introduction/Background, 
Methods, Results, Discussion, Conclusions. 
The following are additional heading or section options that may appear within these: 
• Objectives (within Introduction/Background): a clear statement of the main aim of 
the study and the major hypothesis tested or research question posed 
• Design (within Methods): including factors such as prospective, randomisation, 
blinding, placebo control, case control, crossover, criterion standards for 
diagnostic tests, etc. 
• Setting (within Methods): level of care, e.g. primary, secondary, number of 
participating centres. 
• Participants (instead of patients or subjects; within Methods): numbers entering 
and completing the study, sex, age and any other biological, behavioural, 
social or cultural factors (e.g. smoking status, socioeconomic group, 
educational attainment, co-existing disease indicators, etc)that may have an 
impact on the study results. Clearly define how participants were enrolled, 
and describe selection and exclusion criteria. 
• Interventions (within Methods): what, how, when and for how long. Typically for 
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randomised controlled trials, crossover trials, and before and after studies. 
• Main outcome measures (within Methods): those as planned in the protocol, and 
those ultimately measured. Explain differences, if any. 
  
Results 
• Start with description of the population and sample. Include key characteristics of 
comparison groups. 
• Main results with (for quantitative studies) 95% confidence intervals and, where 
appropriate, the exact level of statistical significance and the number need to 
treat/harm. Whenever possible, state absolute rather than relative risks. 
• Do not replicate data in tables and in text. 
• If presenting mean and standard deviations, specify this clearly. Our house style is 
to present this as follows: 
• E.g.: The mean (SD) birth weight was 2 500 (1 210) g. Do not use the ± symbol 
for mean (SD). 
• Leave interpretation to the Discussion section. The Results section should just 
report the findings as per the Methods section. 
  
Discussion 
Please ensure that the discussion is concise and follows this overall structure – sub-
headings are not needed: 
• Statement of principal findings 
• Strengths and weaknesses of the study 
• Contribution to the body of knowledge 
• Strengths and weaknesses in relation to other studies 
• The meaning of the study – e.g. what this study means to clinicians and 
policymakers 
• Unanswered questions and recommendations for future research 
  
Conclusions 
This may be the only section readers look at, therefore write it carefully. Include 
primary conclusions and their implications, suggesting areas for further research if 
appropriate. Do not go beyond the data in the article. 
 
Illustrations/photos/scans 
• If illustrations submitted have been published elsewhere, the author(s) should 
provide consent to republication obtained from the copyright holder. 
• Figures must be numbered in Arabic numerals and referred to in the text e.g. '(Fig. 
1)'. 
• Each figure must have a caption/legend: Fig. 1. Description (any abbreviations in 
full). 
• All images must be of high enough resolution/quality for print. 
• All illustrations (graphs, diagrams, charts, etc.) must be in PDF form. 
• Ensure all graph axes are labelled appropriately, with a heading/description and 
units (as necessary) indicated. Do not include decimal places if not necessary 
e.g. 0; 1.0; 2.0; 3.0; 4.0 etc. 
• Scans/photos showing a specific feature e.g. Intermediate magnification 
micrograph of a low malignant potential (LMP) mucinous ovarian tumour. 
(H&E stain). –include an arrow to show the tumour. 
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• Each image must be attached individually as a 'supplementary file' upon 
submission (not solely embedded in the accompanying manuscript) and 
named Fig. 1, Fig. 2, etc. 
  
Tables 
• Tables should be constructed carefully and simply for intelligible data 
representation. Unnecessarily complicated tables are strongly discouraged. 
• Large tables will generally not be accepted for publication in their entirety. Please 
consider shortening and using the text to highlight specific important 
sections, or offer a large table as an addendum to the publication, but 
available in full on request from the author 
• Embed/include each table in the manuscript Word file - do not provide separately 
as supplementary files. 
• Number each table in Arabic numerals (Table 1, Table 2, etc.) and refer to 
consecutively in the text. 
• Tables must be cell-based (i.e. not constructed with text boxes or tabs) and 
editable. 
• Ensure each table has a concise title and column headings, and include units where 
necessary. 
• Footnotes must be indicated with consecutive use of the following symbols: * † ‡ 
§ ¶ || then ** †† ‡‡ etc. 
  
Do not: Use [Enter] within a row to make ‘new rows’: 
  
Rather: 
Each row of data must have its own proper row: 
  
Do not: use separate columns for n and %: 
  
Rather: 
Combine into one column, n (%): 
  
Do not: have overlapping categories, e.g.: 
  
Rather: 
Use <> symbols or numbers that don’t overlap: 
  
  
References 
NB: Only complete, correctly formatted reference lists in Vancouver style will be 
accepted. Reference lists must be generated manually and not with the use of 
reference manager software. Endnotes must not be used. 
• Authors must verify references from original sources. 
• Citations should be inserted in the text as superscript numbers between square 
brackets, e.g. These regulations are endorsed by the World Health 
Organization,[2] and others.[3,4-6] 
• All references should be listed at the end of the article in numerical order of 
appearance in the Vancouver style (not alphabetical order). 
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• Approved abbreviations of journal titles must be used; see the List of Journals in 
Index Medicus. 
• Names and initials of all authors should be given; if there are more than six 
authors, the first three names should be given followed by et al. 
• Volume and issue numbers should be given. 
• First and last page, in full, should be given e.g.: 1215-1217 not 1215-17. 
• Wherever possible, references must be accompanied by a digital object identifier 
(DOI) link). Authors are encouraged to use the DOI lookup service offered 
by CrossRef: 
◦ On the Crossref homepage, paste the article title into the ‘Metadata search’ 
box. 
◦ Look for the correct, matching article in the list of results. 
◦ Click Actions > Cite 
◦ Alongside 'url =' copy the URL between { }. 
◦ Provide as follows, e.g.: https://doi.org/10.7196/07294.937.98x 
  
Some examples: 
• Journal references: Price NC, Jacobs NN, Roberts DA, et al. Importance of asking 
about glaucoma. Stat Med 1998;289(1):350-355. 
http://dx.doi.org/10.1000/hgjr.182 
• Book references: Jeffcoate N. Principles of Gynaecology. 4th ed. London: 
Butterworth, 1975:96-101. 
• Chapter/section in a book: Weinstein L, Swartz MN. Pathogenic Properties of 
Invading Microorganisms. In: Sodeman WA, Sodeman WA, eds. Pathologic 
Physiology: Mechanisms of Disease. Philadelphia: WB Saunders, 1974:457-
472. 
• Internet references: World Health Organization. The World Health Report 2002 - 
Reducing Risks, Promoting Healthy Life. Geneva: WHO, 2002. 
http://www.who.int/whr/2002 (accessed 16 January 2010). 
• Legal references 
•              Government Gazettes: 
National Department of Health, South Africa. National Policy for Health Act, 1990 
(Act No. 116 of 1990). Free primary health care services. Government Gazette No. 
17507:1514. 1996. 
 
